MDS Prognostication and Risk Stratification Gene Panel near me in Asansol

Myelodysplastic syndromes (MDS) are diseases of the bone marrow, a type of hematological malignancy. Risk stratification and prognostication are crucial for the appropriate management of patients with myelodysplastic syndromes or myelodysplastic neoplasms. The whole genome sequencing of different subtypes of leukemia has revealed new recurrent genetic and chromosomal abnormalities that add value to the existing prognostic scoring index in different subtypes of hematological malignancies.

The scope of this MDS prognostication and risk stratification gene panel testing includes the screening of the coding regions of a panel of 30 prognostically significant genes through next-generation sequencing for better clinical management.